Vizgen is pushing the boundaries of spatial transcriptomics, providing researchers with both new insight into the biological processes that underlie human health and disease as well as next-generation tools that will drive innovation in drug discovery and diagnostics.
The company’s proprietary MERFISH (Multiplexed Error-Robust Fluorescence in situ Hybridization) technology is a quantitative and genome-scale multiplexed imaging platform for identifying nucleic acids in their native tissue environment with resolution scaling from subcellular to tissue scale.
MISSION
To work tirelessly with researchers to deliver the best tools for spatial biology that enable discoveries to improve human life.
VISION
A world where every disease has a map, and every cure has a path.
